Skip to content

Clinical trial startup Reify Valued at $5 Billion in Round Led by Altimeter, Coatue

  • Investors also include Dragoneer, Iconiq Growth, Adams Street
  • Boston-based company making clinical trials more diverse
Reify Health, whose Care Access business helps clinical trial sponsors diversify the populations in their studies, has raised funds at a $4.8 billion valuation.
Reify Health, whose Care Access business helps clinical trial sponsors diversify the populations in their studies, has raised funds at a $4.8 billion valuation.Source: Reify Health

Reify Health raised $220 million in a funding round that saw its valuation more than double from last year to $4.8 billion.

The series D financing for the Boston-based company was led by Altimeter Capital and Coatue, according to a statement reviewed by Bloomberg News. Dragoneer Investment Group also participated in the round, along with earlier investors Iconiq Growth, Adams Street and Battery Ventures.